Four-dimensional Physics in Two Dimensions By: Penn State News For the first time, physicists have built a two-dimensional experimental system that allows them to study the physical properties of materials that were theorized to exist only in four-dimensional space. An international team of researchers from Penn State, ETH Zurich in Switzerland, [..]
Flexible, Stretchable, and Low-Cost Electronics by Metal Printing By: North Carolina State University News Researchers from North Carolina State University have developed a new technique for directly printing metal circuits, creating flexible, stretchable electronics. The technique can use multiple metals and substrates and is compatible with existing manufacturing systems that employ direct printing [..]
Pain-free Skin Patch Responds to Sugar Levels for Management of Type 2 Diabetes By: NIBIB News For millions of people with type 2 diabetes, ongoing vigilance over the amount of sugar, or glucose, in their blood is the key to health. A finger prick before mealtimes and maybe an insulin [..]
Diabetes drug “significantly reverses memory loss” in mice with Alzheimer’s By: Lancaster University News The research, published in Brain Research, could bring substantial improvements in the treatment of Alzheimer’s disease through the use of a drug originally created to treat type 2 diabetes. Lead researcher Professor Christian Holscher of Lancaster University in [..]
This will Help to Improve Early Diagnosis of Kidney Stone Disease By: NUS News An interdisciplinary research team led by the National University of Singapore (NUS) has recently discovered a unique panel of urine biomarkers that could accurately diagnose nephrolithiasis, also commonly known as kidney stone. These urine biomarkers may potentially [..]
Your Motivation, Your Goal! By: Vijay Soni, Ph.D. | Founder and C.E.O. Scipreneur One of the biggest challenges in meeting any goal, whether it be related to productivity, waking early, changing a habit, exercising, or just becoming happier, is finding the motivation to stick with it. If you can stick with a goal for [..]
Novartis drug Tasigna® is approved by FDA For CML By: Novartis Media Release Novartis announced that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label. Tasigna is now the first and only BCR-ABL tyrosine kinase inhibitor (TKI) to [..]
Turning Pathogens Against Each Other to Prevent Drug Resistance By: University of Michigan News Limiting a much-needed resource could pit pathogens against one another and prevent the emergence of drug resistance. New research demonstrates that harnessing competition among pathogens inside a patient could extend the life of existing drugs where resistance [..]
Let’s Overcome the Fear of Success (Easy Confidence Trick) By: Vijay Soni, Ph.D. | Founder and C.E.O. Scipreneur Every time when we try something new your fear of success will arise and sabotages your mind from victory. We all have that fear of success. It’s a part of our personality and the only [..]
First Drug for Eosinophilic Granulomatosis with Polyangiitis (EGPA) of GSK Approved by FDA By: GSK News GlaxoSmithKline plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as the first targeted treatment for eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome. GSK [..]
FDA Approves Sanofi-Aventis’s Admelog to Treat Diabetes: The First Short-Acting “Follow-On” Insulin Product By: Sanofi-Aventis News The U.S. Food and Drug Administration (FDA) has approved Sanofi’s Admelog®, the first follow-on insulin lispro to help people living with diabetes manage blood sugar levels at mealtime. “Sanofi has a deep heritage and broad [..]
This New Tool by FDA Will Help Doctors to Better Manage Antibiotic Use By: FDA News The U.S. Food and Drug Administration is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care professionals as part of an overall effort to combat antimicrobial resistance. [..]
10 Things Successful People do for Motivation By: Vijay Soni, Ph.D. | Founder and C.E.O. Scipreneur What I’ve noticed over the time of my life is that there is a recurring pattern to successfully motivating myself. This pattern helped me get back on track, even during times that felt like rock bottom. I’ve also asked numerous executives [..]
Entrepreneur? Must Read These Books By: Vijay Soni | Founder & C.E.O. Scipreneur Reading book is the most important way to improvise yourself as a leader. Because someone who doesn’t read is going to make more dumb mistakes than someone who reads and pays attention. There are some survey books that [..]
U.S. FDA Approves Mylan and Biocon’s Ogivri™, for HER2-Positive Breast and Gastric Cancers By: PRNewswire HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India,/PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) announced that the U.S. Food and Drug Administration (FDA) has approved Mylan’s Ogivri™(trastuzumab-dkst), a biosimilar to Herceptin® (trastuzumab), co-developed with Biocon. Ogivri [..]
FDA Grants Full Approval to Genentech’s Avastin for Brain Cancer By: Genentech News Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has granted full approval for Avastin®(bevacizumab) for the treatment of adults with glioblastoma that progressed following prior [..]
Rxsight’s Light Adjustable Lens Got FDA Approval By: RxSight, Inc. News ALISO VIEJO, Calif., RxSight, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the RxSight™ Light Adjustable Lens and the Light Delivery Device (LDD) for patients with pre-existing astigmatism of ≥ 0.75 diopters undergoing cataract surgery. This [..]
FDA Approved ViiV’s Juluca® For HIV By: ViiV Healthcare News ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, announced that the US Food and Drug Administration (FDA) has approved Juluca®, indicated as a complete regimen for the maintenance treatment of HIV-1 [..]
Making Fuel From Emissions By: David L. Chandler | MIT News Office MIT researchers have developed a new system that could potentially be used for converting power plant emissions of carbon dioxide into useful fuels for cars, trucks, and planes, as well as into chemical feedstocks for a wide variety [..]
New Direction for Autoimmune Drug Design Inspired by Viral Protein By: Susan Gammon | SBP Beaker Blog In the U.S. alone, 24 million people, or eight percent of the population, have autoimmune diseases such as rheumatoid arthritis, lupus, multiple sclerosis, and psoriasis. Current treatments, including the new wave of biologic [..]
FDA Approved Pfizer’s Sutent® For Renal Cell Carcinoma By: Pfizer News Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT® (sunitinib malate) to include the adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma [..]
Collision Conference NEW ORLEANS, April 30 – May 3, 2018 From the organizers of Web Summit, Collision is regarded as one of the best conferences in the world for tech entrepreneurs. Many of my peers rave about every aspect of this conference: From [..]
FDA Approved Genentech’s Hemlibra for Hemophilia A By: Genentech News Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA® (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children [..]
Ultragenyx’s MEPSEVII™ Got FDA Approval NOVATO, Calif., (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, announced that the U.S. Food and Drug Administration (FDA) has approved MEPSEVII™ (vestronidase alfa), the first medicine approved for the treatment of [..]
Manta Ray Robot By NUS Scientists Which Can Swims Faster and Operates up to 10 Hours By: NUS News Researchers from the National University of Singapore (NUS) have created MantaDroid, an aquatic robot that emulates the swimming locomotion of manta rays. The robotic manta ray, which swims at the speed of twice [..]
Now You Can Get Your Blood Test Results In Minutes, On-site, With New Sysmex XW-100 : F.D.A. Approved Sysmex America announced that its Sysmex XW-100 received clearance from the U.S. Food and Drug Administration (FDA)—making it the first Clinical Laboratory Improvement Amendments (CLIA)-waived, complete blood count (CBC) system. Once prepared for each [..]
Novel Way to Make Nanoscale Emulsions By: David L. Chandler | MIT News Office The reluctance of oil and water to mix together and stay that way is so well-known that it has become a cliché for describing any two things that do not go together well. Now, a new [..]
Flexible and Stretchable Photonic Devices Developed by MIT Researchers By: David L. Chandler | MIT News Office Researchers at MIT and several other institutions have developed a method for making photonic devices — similar to electronic devices but based on light rather than electricity — that can bend and stretch [..]
Patent is the Starting, Not the End! By: Vijay Soni, Ph.D. | Founder Scipreneur Many patent attorneys, especially pay-for-services outside counsel, are giving terrible advice that is purely self-serving. Their advice is only designed to put money in their pocket at the expense of their clients, but masquerades by “helping” [..]
12th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 26- 27, 2018 London, UK Theme: Latest Trends in Pharmacy : Spanning the Gap in Research and Product Commercialization Meet Inspiring Speakers and Experts at our 3000+ Global Eventswith over 600+ Conferences, 1200+ Symposiums and 1200+ [..]
Copyright © 2024 | WordPress Theme by MH Themes